Cargando…
Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance
Mitochondrial pyruvate carrier (MPC) is known to cause different expressions in normal and cancer cells. We observed a change in phenotype with the suppression of MPC expression. We knocked down MPC1 and/or MPC2 using siRNA or shRNA. We observed its cell morphology and accompanying molecular marker....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447954/ https://www.ncbi.nlm.nih.gov/pubmed/30801869 http://dx.doi.org/10.1111/cas.13980 |
_version_ | 1783408601199542272 |
---|---|
author | Takaoka, Yuji Konno, Masamitsu Koseki, Jun Colvin, Hugh Asai, Ayumu Tamari, Keisuke Satoh, Taroh Mori, Masaki Doki, Yuichiro Ogawa, Kazuhiko Ishii, Hideshi |
author_facet | Takaoka, Yuji Konno, Masamitsu Koseki, Jun Colvin, Hugh Asai, Ayumu Tamari, Keisuke Satoh, Taroh Mori, Masaki Doki, Yuichiro Ogawa, Kazuhiko Ishii, Hideshi |
author_sort | Takaoka, Yuji |
collection | PubMed |
description | Mitochondrial pyruvate carrier (MPC) is known to cause different expressions in normal and cancer cells. We observed a change in phenotype with the suppression of MPC expression. We knocked down MPC1 and/or MPC2 using siRNA or shRNA. We observed its cell morphology and accompanying molecular marker. Furthermore, the radioresistance of the MPC knockdown cell line was examined using a colony formation assay. MPC1‐suppressed cells changed their morphology to a spindle shape. Epithelial‐mesenchymal transition (EMT) was suspected, and examination of the EMT marker by PCR showed a decrease in E‐cadherin and an increase in fibronectin. Focusing on glutamine metabolism as the mechanism of this phenomenon, we knocked down the glutamine‐metabolizing enzyme glutaminase (GLS). EMT was also observed in GLS‐suppressed cells. Furthermore, when MPC1‐suppressed cells were cultured in a glutamine‐deficient medium, changes in EMT markers were suppressed. In addition, MPC1‐suppressed cells also increased with a significant difference in radioresistance. Decreased MPC1 expression favorably affects EMT and radioresistance of cancer. |
format | Online Article Text |
id | pubmed-6447954 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64479542019-04-15 Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance Takaoka, Yuji Konno, Masamitsu Koseki, Jun Colvin, Hugh Asai, Ayumu Tamari, Keisuke Satoh, Taroh Mori, Masaki Doki, Yuichiro Ogawa, Kazuhiko Ishii, Hideshi Cancer Sci Original Articles Mitochondrial pyruvate carrier (MPC) is known to cause different expressions in normal and cancer cells. We observed a change in phenotype with the suppression of MPC expression. We knocked down MPC1 and/or MPC2 using siRNA or shRNA. We observed its cell morphology and accompanying molecular marker. Furthermore, the radioresistance of the MPC knockdown cell line was examined using a colony formation assay. MPC1‐suppressed cells changed their morphology to a spindle shape. Epithelial‐mesenchymal transition (EMT) was suspected, and examination of the EMT marker by PCR showed a decrease in E‐cadherin and an increase in fibronectin. Focusing on glutamine metabolism as the mechanism of this phenomenon, we knocked down the glutamine‐metabolizing enzyme glutaminase (GLS). EMT was also observed in GLS‐suppressed cells. Furthermore, when MPC1‐suppressed cells were cultured in a glutamine‐deficient medium, changes in EMT markers were suppressed. In addition, MPC1‐suppressed cells also increased with a significant difference in radioresistance. Decreased MPC1 expression favorably affects EMT and radioresistance of cancer. John Wiley and Sons Inc. 2019-04-04 2019-04 /pmc/articles/PMC6447954/ /pubmed/30801869 http://dx.doi.org/10.1111/cas.13980 Text en © 2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Takaoka, Yuji Konno, Masamitsu Koseki, Jun Colvin, Hugh Asai, Ayumu Tamari, Keisuke Satoh, Taroh Mori, Masaki Doki, Yuichiro Ogawa, Kazuhiko Ishii, Hideshi Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance |
title | Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance |
title_full | Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance |
title_fullStr | Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance |
title_full_unstemmed | Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance |
title_short | Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance |
title_sort | mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447954/ https://www.ncbi.nlm.nih.gov/pubmed/30801869 http://dx.doi.org/10.1111/cas.13980 |
work_keys_str_mv | AT takaokayuji mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT konnomasamitsu mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT kosekijun mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT colvinhugh mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT asaiayumu mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT tamarikeisuke mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT satohtaroh mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT morimasaki mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT dokiyuichiro mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT ogawakazuhiko mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance AT ishiihideshi mitochondrialpyruvatecarrier1expressioncontrolscancerepithelialmesenchymaltransitionandradioresistance |